ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Triple Negative Breast Cancer
Adenocarcinoma

Endometrial Cancer trials near Rochester, MN, USA:

Locations recently updated

A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer (EMBER)

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Rochester, Minnesota, United States and 72 other locations

This study, ELU- FRα-1, is focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors con...

Active, not recruiting
Ovarian Cancer Stage
Fallopian Tube Cancer
Drug: ELU001

Phase 1, Phase 2

Elucida Oncology

Rochester, Minnesota, United States and 16 other locations

first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer...

Enrolling
Endometrial Cancer
Ovarian Cancer
Drug: TORL-1-23

Phase 1

TORL Biotherapeutics

Rochester, Minnesota, United States and 3 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Rochester, Minnesota, United States and 123 other locations

can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...

Enrolling
Recurrent Primary Peritoneal Cancer
Recurrent Ovarian Cancer
Drug: REGN4018
Drug: Sarilumab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Rochester, Minnesota, United States and 49 other locations

A Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patie...

Enrolling
Breast Cancer
Esophageal Cancer
Drug: AMXT1501
Drug: DFMO

Phase 1, Phase 2

Aminex Therapeutics

Rochester, Minnesota, United States and 6 other locations

The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...

Active, not recruiting
Endometrial Carcinoma
Non-small Cell Lung Cancer
Biological: Acasunlimab in combination with pembrolizumab (in a separate expansion cohort)
Biological: Acasunlimab in combination with docetaxel (in a single expansion cohort)

Phase 1, Phase 2

Genmab
Genmab

Rochester, Minnesota, United States and 56 other locations

This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (al...

Enrolling
Neoplasms
Biological: Dostarlimab

Phase 1

Tesaro
Tesaro

Rochester, Minnesota, United States and 144 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems